Abnormal expression of PFDN4 in colorectal cancer: A novel marker for prognosis

Norikatsu Miyoshi, Hideshi Ishii, Koshi Mimori, Naohiro Nishida, Masayoshi Tokuoka, Hirofumi Akita, Mitsugu Sekimoto, Yuichiro Doki, Masaki Mori

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Prefoldin 4 (PFDN4) is a transcriptional factor that regulates the cell cycle. PFDN4 is upregulated in breast tumor and breast cancer cell lines, but its significance in colorectal cancer (CRC) is not fully understood. Methods: The present study assessed 129 patients who underwent surgery for CRC and assessed three cell lines derived from human CRC. The correlation of gene expression with clinical parameters in patients was assessed by knockdown experiments with these cell lines. Results: Patients with high PFDN4 expression had a statistically relatively better prognosis, and those with low PFDN4 expression showed poorer overall survival than those with high expression. The assessment of PFDN4 knockdown in the three cell lines demonstrated that the siRNA inhibition resulted in a statistically significant increase in cell growth and invasiveness. Conclusions: The data strongly suggest that PFDN4 expression is a prognostic factor in CRC.

Original languageEnglish
Pages (from-to)3030-3036
Number of pages7
JournalAnnals of Surgical Oncology
Volume17
Issue number11
DOIs
Publication statusPublished - Nov 1 2010

Fingerprint

Colorectal Neoplasms
Cell Line
Breast Neoplasms
Small Interfering RNA
prefoldin
Cell Cycle
Gene Expression
Survival
Growth

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Abnormal expression of PFDN4 in colorectal cancer : A novel marker for prognosis. / Miyoshi, Norikatsu; Ishii, Hideshi; Mimori, Koshi; Nishida, Naohiro; Tokuoka, Masayoshi; Akita, Hirofumi; Sekimoto, Mitsugu; Doki, Yuichiro; Mori, Masaki.

In: Annals of Surgical Oncology, Vol. 17, No. 11, 01.11.2010, p. 3030-3036.

Research output: Contribution to journalArticle

Miyoshi, N, Ishii, H, Mimori, K, Nishida, N, Tokuoka, M, Akita, H, Sekimoto, M, Doki, Y & Mori, M 2010, 'Abnormal expression of PFDN4 in colorectal cancer: A novel marker for prognosis', Annals of Surgical Oncology, vol. 17, no. 11, pp. 3030-3036. https://doi.org/10.1245/s10434-010-1138-5
Miyoshi, Norikatsu ; Ishii, Hideshi ; Mimori, Koshi ; Nishida, Naohiro ; Tokuoka, Masayoshi ; Akita, Hirofumi ; Sekimoto, Mitsugu ; Doki, Yuichiro ; Mori, Masaki. / Abnormal expression of PFDN4 in colorectal cancer : A novel marker for prognosis. In: Annals of Surgical Oncology. 2010 ; Vol. 17, No. 11. pp. 3030-3036.
@article{8d9cb53c58f34617989e83e470fe6ed4,
title = "Abnormal expression of PFDN4 in colorectal cancer: A novel marker for prognosis",
abstract = "Background: Prefoldin 4 (PFDN4) is a transcriptional factor that regulates the cell cycle. PFDN4 is upregulated in breast tumor and breast cancer cell lines, but its significance in colorectal cancer (CRC) is not fully understood. Methods: The present study assessed 129 patients who underwent surgery for CRC and assessed three cell lines derived from human CRC. The correlation of gene expression with clinical parameters in patients was assessed by knockdown experiments with these cell lines. Results: Patients with high PFDN4 expression had a statistically relatively better prognosis, and those with low PFDN4 expression showed poorer overall survival than those with high expression. The assessment of PFDN4 knockdown in the three cell lines demonstrated that the siRNA inhibition resulted in a statistically significant increase in cell growth and invasiveness. Conclusions: The data strongly suggest that PFDN4 expression is a prognostic factor in CRC.",
author = "Norikatsu Miyoshi and Hideshi Ishii and Koshi Mimori and Naohiro Nishida and Masayoshi Tokuoka and Hirofumi Akita and Mitsugu Sekimoto and Yuichiro Doki and Masaki Mori",
year = "2010",
month = "11",
day = "1",
doi = "10.1245/s10434-010-1138-5",
language = "English",
volume = "17",
pages = "3030--3036",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "11",

}

TY - JOUR

T1 - Abnormal expression of PFDN4 in colorectal cancer

T2 - A novel marker for prognosis

AU - Miyoshi, Norikatsu

AU - Ishii, Hideshi

AU - Mimori, Koshi

AU - Nishida, Naohiro

AU - Tokuoka, Masayoshi

AU - Akita, Hirofumi

AU - Sekimoto, Mitsugu

AU - Doki, Yuichiro

AU - Mori, Masaki

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Background: Prefoldin 4 (PFDN4) is a transcriptional factor that regulates the cell cycle. PFDN4 is upregulated in breast tumor and breast cancer cell lines, but its significance in colorectal cancer (CRC) is not fully understood. Methods: The present study assessed 129 patients who underwent surgery for CRC and assessed three cell lines derived from human CRC. The correlation of gene expression with clinical parameters in patients was assessed by knockdown experiments with these cell lines. Results: Patients with high PFDN4 expression had a statistically relatively better prognosis, and those with low PFDN4 expression showed poorer overall survival than those with high expression. The assessment of PFDN4 knockdown in the three cell lines demonstrated that the siRNA inhibition resulted in a statistically significant increase in cell growth and invasiveness. Conclusions: The data strongly suggest that PFDN4 expression is a prognostic factor in CRC.

AB - Background: Prefoldin 4 (PFDN4) is a transcriptional factor that regulates the cell cycle. PFDN4 is upregulated in breast tumor and breast cancer cell lines, but its significance in colorectal cancer (CRC) is not fully understood. Methods: The present study assessed 129 patients who underwent surgery for CRC and assessed three cell lines derived from human CRC. The correlation of gene expression with clinical parameters in patients was assessed by knockdown experiments with these cell lines. Results: Patients with high PFDN4 expression had a statistically relatively better prognosis, and those with low PFDN4 expression showed poorer overall survival than those with high expression. The assessment of PFDN4 knockdown in the three cell lines demonstrated that the siRNA inhibition resulted in a statistically significant increase in cell growth and invasiveness. Conclusions: The data strongly suggest that PFDN4 expression is a prognostic factor in CRC.

UR - http://www.scopus.com/inward/record.url?scp=78049474162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049474162&partnerID=8YFLogxK

U2 - 10.1245/s10434-010-1138-5

DO - 10.1245/s10434-010-1138-5

M3 - Article

C2 - 20552408

AN - SCOPUS:78049474162

VL - 17

SP - 3030

EP - 3036

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 11

ER -